All forthcoming seminars - MicroRNAs drive ibrutinib resistance in mantle cell lymphoma via the AKT/PIK3 and MAPK pathways - (2023/2024)-Dep.Medicine-University of Verona

No recent seminar found relating to teaching MicroRNAs drive ibrutinib resistance in mantle cell lymphoma via the AKT/PIK3 and MAPK pathways.

Share

Piazzale Ludovico Antonio Scuro 10
37124 Verona
VAT number01541040232
Italian Fiscal Code93009870234

Play store Apple Store

All forthcoming seminars - MicroRNAs drive ibrutinib resistance in mantle cell lymphoma via the AKT/PIK3 and MAPK pathways - (2023/2024)